Released Mar 17, 2017, after the close
10-Q filed Mar 17, 2017, 45 days after period end · 0001654954-17-002146
Q1 2017 · 10-Q
Revenue—
Net Income-$382.14K-$382.14K N/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$0.02-$0.02 N/M vs Q1 2016no prior Q4 2016 on file
Gross Profit$1,032,345−41.3%
Operating Income-$383,997N/M
Operating Cash Flow$185,391+156.3%
Free Cash Flowderived-$95,331N/M
What the release said
The release
Same quarter
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$382.14K | $350.01K | $288.39K | $661.93K |
| EPS Diluted | -$0.02 | $0.02 | $0.01 | $0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR